Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)
- PMID: 25329461
- PMCID: PMC4199494
- DOI: 10.1371/journal.pgen.1004681
Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)
Erratum in
- PLoS Genet. 2014 Nov;10(11):e1004882
Abstract
Interferon lambda 4 gene (IFNL4) encodes IFN-λ4, a new member of the IFN-λ family with antiviral activity. In humans IFNL4 open reading frame is truncated by a polymorphic frame-shift insertion that eliminates IFN-λ4 and turns IFNL4 into a polymorphic pseudogene. Functional IFN-λ4 has antiviral activity but the elimination of IFN-λ4 through pseudogenization is strongly associated with improved clearance of hepatitis C virus (HCV) infection. We show that functional IFN-λ4 is conserved and evolutionarily constrained in mammals and thus functionally relevant. However, the pseudogene has reached moderately high frequency in Africa, America, and Europe, and near fixation in East Asia. In fact, the pseudogenizing variant is among the 0.8% most differentiated SNPs between Africa and East Asia genome-wide. Its raise in frequency is associated with additional evidence of positive selection, which is strongest in East Asia, where this variant falls in the 0.5% tail of SNPs with strongest signatures of recent positive selection genome-wide. Using a new Approximate Bayesian Computation (ABC) approach we infer that the pseudogenizing allele appeared just before the out-of-Africa migration and was immediately targeted by moderate positive selection; selection subsequently strengthened in European and Asian populations resulting in the high frequency observed today. This provides evidence for a changing adaptive process that, by favoring IFN-λ4 inactivation, has shaped present-day phenotypic diversity and susceptibility to disease.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
IFN-λ4: the paradoxical new member of the interferon lambda family.J Interferon Cytokine Res. 2014 Nov;34(11):829-38. doi: 10.1089/jir.2013.0136. Epub 2014 Apr 30. J Interferon Cytokine Res. 2014. PMID: 24786669 Free PMC article. Review.
-
IFNL4 Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa.J Interferon Cytokine Res. 2023 Sep;43(9):394-402. doi: 10.1089/jir.2023.0014. Epub 2023 Jun 27. J Interferon Cytokine Res. 2023. PMID: 37366802 Free PMC article.
-
Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.Gene. 2018 Jul 20;664:168-180. doi: 10.1016/j.gene.2018.04.076. Epub 2018 Apr 27. Gene. 2018. PMID: 29705128 Review.
-
Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.J Interferon Cytokine Res. 2017 Aug;37(8):369-382. doi: 10.1089/jir.2017.0002. Epub 2017 Jul 20. J Interferon Cytokine Res. 2017. PMID: 28727946
-
Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.Scand J Gastroenterol. 2021 Jul;56(7):855-861. doi: 10.1080/00365521.2021.1925956. Epub 2021 May 25. Scand J Gastroenterol. 2021. PMID: 34034600
Cited by
-
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.Immunity. 2015 Jul 21;43(1):15-28. doi: 10.1016/j.immuni.2015.07.001. Immunity. 2015. PMID: 26200010 Free PMC article. Review.
-
Low Diversity of Human Variation Despite Mostly Mild Functional Impact of De Novo Variants.Front Mol Biosci. 2021 Mar 18;8:635382. doi: 10.3389/fmolb.2021.635382. eCollection 2021. Front Mol Biosci. 2021. PMID: 33816556 Free PMC article.
-
The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation.J Virol. 2020 Feb 14;94(5):e01535-19. doi: 10.1128/JVI.01535-19. Print 2020 Feb 14. J Virol. 2020. PMID: 31776283 Free PMC article.
-
Immune Gene Diversity in Archaic and Present-day Humans.Genome Biol Evol. 2019 Jan 1;11(1):232-241. doi: 10.1093/gbe/evy271. Genome Biol Evol. 2019. PMID: 30566634 Free PMC article.
-
Shared and Distinct Functions of Type I and Type III Interferons.Immunity. 2019 Apr 16;50(4):907-923. doi: 10.1016/j.immuni.2019.03.025. Immunity. 2019. PMID: 30995506 Free PMC article. Review.
References
-
- Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2002) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63–68. - PubMed
-
- Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2002) IFN-θs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69–77. - PubMed
-
- Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105–1109. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases